TIBER CREEK HEALTH STRATEGIES, INC.

Lobbying for GENENTECH, INC. · Biotechnology.

Filing Q4 reportNo activity

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.